Gilead Sciences Aktie

NeuKaufen Kaufen Verkaufen Verkaufen

Aktien-Sparplan anlegen Aktien-Sparplan anlegen

84,20 EUR +0,04 EUR +0,05 %

15:32:05

STU

88,32 USD -0,30 USD -0,34 %

15:50:16

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Smartphone

Marktkap.103,79 Mrd. EUR

KGV17,99Div. Rendite3,70%

WKN885823

ISINUS3755581036

SymbolGILD

Werbung

Gilead Sciences Aktien News

Sortieren:Datum Meistgelesen

30.01.24BenzingaPharma Giant Gilead Raises Stake In Cancer-Focused Arcus Biosciences, Stock Soars

29.01.24ZacksGilead Sciences (GILD) Stock Sinks As Market Gains: Here's Why

18.01.24BenzingaAbbVie, Arch Capital, Gilead Sciences And A Telecom Giant On CNBC's 'Final Trades'

18.01.24ZacksGilead Sciences (GILD) Rises As Market Takes a Dip: Key Facts

12.01.24Benzinga$1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today

12.01.24ZacksGilead Sciences (GILD) Increases Despite Market Slip: Here's What You Need to Know

06.01.24ZacksGilead Sciences (GILD) Stock Falls Amid Market Uptick: What Investors Need to Know

03.01.24Benzinga(GILD) - Analyzing Gilead Sciences's Short Interest

30.12.23ZacksGilead Sciences (GILD) Stock Moves -0.16%: What You Should Know

22.12.23BenzingaA Look Into Gilead Sciences Inc's Price Over Earnings

20.12.23ZacksGilead Sciences (GILD) Stock Moves -1.13%: What You Should Know

20.12.23ZacksGilead (GILD), Compugen Collaborate for Immunotherapy Program

20.12.23PR NewswireRedHill and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola

19.12.23GlobesCompugen signs cancer drug licensing deal with Gilead Sciences

19.12.23MarketWatchCompugen’s stock rockets on deal with Gilead for anti-tumor drug

18.12.23Benzinga(GILD) - Analyzing Gilead Sciences's Short Interest

15.12.23ZacksGilead (GILD) Outperforms Industry in 6 Months: What Lies Ahead?

14.12.23ZacksGilead Sciences (GILD) Stock Sinks As Market Gains: Here's Why

11.12.23BenzingaGilead Sciences Battles Rising Threat of Drug Counterfeiting, Initiates Legal Actions

08.12.23ZacksGilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know

07.12.23ZacksWhy Is Gilead (GILD) Up 1.9% Since Last Earnings Report?

07.12.23BenzingaA Look Into Gilead Sciences Inc's Price Over Earnings

29.11.23BenzingaEyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies

24.11.23ZacksZacks Industry Outlook Highlights Gilead Sciences, CRISPR Therapeutics, ACADIA Pharmaceuticals, Dynavax and Ligand Pharmaceuticals

22.11.23BenzingaLooking Into Gilead Sciences's Recent Short Interest

21.11.23ZacksThe Zacks Analyst Blog Highlights Gilead Sciences, Legend Biotech, BeiGene, Exact Sciences and Sarepta Therapeutics

16.11.23ZacksArcellx (ACLX) Up 5% on Partnership Expansion With Gilead

15.11.23PR NewswireARCELLX AND KITE ANNOUNCE EXPANSION IN STRATEGIC PARTNERSHIP

28.07.23PR NewswireGILEAD LAUNCHES GLOBAL ALL4LIVER GRANT PROGRAM TO HELP ACHIEVE THE WORLD HEALTH ORGANIZATION'S GOAL OF VIRAL HEPATITIS ELIMINATION BY 2030

24.07.23PR NewswireCognizant and Gilead Extend Partnership with Five-Year Service Agreement Estimated at $800 Million

09.12.22PR NewswireArcellx and Kite Announce Strategic Collaboration to Co-Develop and Co-Commercialize Late-Stage Clinical CART-ddBCMA in Multiple Myeloma

10.11.22RSSForm 4 882095

02.11.22RSSForm 10-Q 882095

27.10.22RSSForm 8-K 882095

08.08.22RSSStatement of acquisition of beneficial ownership by individuals

05.08.22RSSInitial statement of beneficial ownership of securities

04.06.22PR NewswireEverest Medicines' Licensing Partner Gilead Sciences Announces Positive Results from Phase 3 TROPiCS-02 Study of Trodelvy® in Heavily Pre-treated HR+/HER2- Metastatic Breast Cancer Patients

04.06.22PR NewswireEverest Medicines' Licensing Partner Gilead Sciences Announces Positive Results from Phase 3 TROPiCS-02 Study of Trodelvy® in Heavily Pre-treated HR+/HER2- Metastatic Breast Cancer Patients

05.05.22RSSForm S-8 882095

13.04.22RSSForm 4 882095

Gilead Sciences News

Gilead Sciences News: auf dieser Seite finden Sie alle Gilead Sciences News und Nachrichten zur Gilead Sciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Gilead Sciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Gilead Sciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.